NCT01893424View on ClinicalTrials.gov

Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2015

Conditions
Pain
Interventions
DRUG

Sativex buccal spray

buccal spray

DRUG

CBD-THC-Piperine-PNL capsule

a capsule containing Cannabidiol and Tetrahydrocannabinol combination

Trial Locations (1)

Unknown

Hadassah medical organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT01893424 - Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol) | Biotech Hunter | Biotech Hunter